Free Trial
NASDAQ:ATOS

Atossa Genetics (ATOS) Stock Price, News & Analysis

Atossa Genetics logo
$1.01 +0.09 (+9.78%)
Closing price 10/3/2025 04:00 PM Eastern
Extended Trading
$1.01 +0.00 (+0.10%)
As of 07:12 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Atossa Genetics Stock (NASDAQ:ATOS)

Advanced

Key Stats

Today's Range
$0.92
$1.05
50-Day Range
$0.74
$1.01
52-Week Range
$0.55
$1.66
Volume
3.02 million shs
Average Volume
762,207 shs
Market Capitalization
$130.46 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$6.25
Consensus Rating
Moderate Buy

Company Overview

Atossa Genetics Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
44th Percentile Overall Score

ATOS MarketRank™: 

Atossa Genetics scored higher than 44% of companies evaluated by MarketBeat, and ranked 647th out of 944 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Atossa Genetics has received a consensus rating of Moderate Buy. The company's average rating score is 2.75, and is based on 2 buy ratings, no hold ratings, and 1 sell rating.

  • Upside Potential

    Atossa Genetics has a consensus price target of $6.25, representing about 518.8% upside from its current price of $1.01.

  • Amount of Analyst Coverage

    Atossa Genetics has only been the subject of 2 research reports in the past 90 days.

  • Read more about Atossa Genetics' stock forecast and price target.
  • Earnings Growth

    Earnings for Atossa Genetics are expected to decrease in the coming year, from ($0.22) to ($0.28) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Atossa Genetics is -4.39, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Atossa Genetics is -4.39, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Atossa Genetics has a P/B Ratio of 1.77. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Read more about Atossa Genetics' valuation and earnings.
  • Percentage of Shares Shorted

    2.17% of the outstanding shares of Atossa Genetics have been sold short.
  • Short Interest Ratio / Days to Cover

    Atossa Genetics has a short interest ratio ("days to cover") of 2.6, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Atossa Genetics has recently decreased by 21.57%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    Atossa Genetics does not currently pay a dividend.

  • Dividend Growth

    Atossa Genetics does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    2.17% of the outstanding shares of Atossa Genetics have been sold short.
  • Short Interest Ratio / Days to Cover

    Atossa Genetics has a short interest ratio ("days to cover") of 2.6, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Atossa Genetics has recently decreased by 21.57%, indicating that investor sentiment is improving significantly.
  • News Coverage This Week

    MarketBeat has tracked 1 news article for Atossa Genetics this week, compared to 2 articles on an average week.
  • Search Interest

    17 people have searched for ATOS on MarketBeat in the last 30 days. This is an increase of 240% compared to the previous 30 days.
  • MarketBeat Follows

    5 people have added Atossa Genetics to their MarketBeat watchlist in the last 30 days. This is an increase of 400% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Atossa Genetics insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 8.70% of the stock of Atossa Genetics is held by insiders.

  • Percentage Held by Institutions

    Only 12.74% of the stock of Atossa Genetics is held by institutions.

  • Read more about Atossa Genetics' insider trading history.
Receive ATOS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Atossa Genetics and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

ATOS Stock News Headlines

Get my No. 1 gold stock now
Gold recently broke past $3,800 per ounce – setting yet another new all-time high. And Wall Street banks say this is just the beginning... Because there's mounting evidence that a 40% market crash could be on the way.tc pixel
See More Headlines

ATOS Stock Analysis - Frequently Asked Questions

Atossa Genetics' stock was trading at $0.9441 at the start of the year. Since then, ATOS shares have increased by 7.0% and is now trading at $1.01.

Atossa Genetics Inc. (NASDAQ:ATOS) posted its earnings results on Tuesday, August, 12th. The company reported ($0.07) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.06) by $0.01.

Atossa Genetics shares reverse split before market open on Friday, April 20th 2018.The 1-12 reverse split was announced on Friday, April 20th 2018. The number of shares owned by shareholders was adjusted after the market closes on Thursday, April 19th 2018. An investor that had 100 shares of stock prior to the reverse split would have 8 shares after the split.

Shares of ATOS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Atossa Genetics investors own include Zomedica (ZOM), AU Optronics (AUOTY), Voyager Therapeutics (VYGR), DiamondRock Hospitality (DRH), Waste Connections (WCN), American Water Works (AWK) and The RMR Group (RMR).

Company Calendar

Last Earnings
8/12/2025
Today
10/06/2025
Next Earnings (Estimated)
11/11/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED INSTRUMENTS
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:ATOS
CIK
1488039
Employees
8
Year Founded
2009

Price Target and Rating

High Price Target
$7.75
Low Price Target
$4.00
Potential Upside/Downside
+518.8%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.75
Research Coverage
4 Analysts

Profitability

EPS (Trailing Twelve Months)
($0.23)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$25.50 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-40.28%
Return on Assets
-37.10%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
9.17
Quick Ratio
9.17

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.57 per share
Price / Book
1.77

Miscellaneous

Outstanding Shares
129,170,000
Free Float
117,933,000
Market Cap
$130.46 million
Optionable
Optionable
Beta
1.11

Social Links

(Almost)  Everything You Need To Know About The EV Market Cover

Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.

Get This Free Report

This page (NASDAQ:ATOS) was last updated on 10/6/2025 by MarketBeat.com Staff
From Our Partners